Immunoglobulin G4–Related Sclerosing Cholangitis
Clinics in Liver Disease · 2026-08 · 30 (3) · 761-774
DOI: 10.1016/j.cld.2026.04.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2026-08. Verfasst von Kareem Khalaf und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, St. Michael's Hospital, University of Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Immunoglobulin G4-Related Disease, Immunoglobulin G. Die Arbeit nennt 69 Literaturangaben.
Abstract (Originalsprache)
Immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) is a steroid-responsive biliary manifestation of IgG4-related disease, commonly associated with type I autoimmune pancreatitis and can mimic primary SC or cholangiocarcinoma. Diagnosis relies on the histology, imaging, serology, other-organ involvement, and response to therapy criteria. First-line therapy is corticosteroids; relapsing or refractory disease requires steroid-sparing immunomodulators or B cell-targeted therapy (rituximab).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, St. Michael's Hospital, University of Toronto, Ontario, Canada.
- Division of Gastroenterology, St. Michael's Hospital, University of Toronto, Ontario, Canada. Electronic address: natalia.calo@unityhealth.to.
Zitieren
APA
Khalaf, K., & Calo, N. C. (2026). Immunoglobulin G4–Related Sclerosing Cholangitis. Clinics in Liver Disease, 30(3), 761-774. https://doi.org/10.1016/j.cld.2026.04.004
Vancouver
Khalaf K, Calo NC. Immunoglobulin G4–Related Sclerosing Cholangitis. Clinics in Liver Disease. 2026;30(3):761-774. doi:10.1016/j.cld.2026.04.004
BibTeX
@article{Khalaf2026,
author = {Khalaf, Kareem and Calo, Natalia Causada},
title = {Immunoglobulin G4–Related Sclerosing Cholangitis},
journal = {Clinics in Liver Disease},
year = {2026},
volume = {30},
number = {3},
pages = {761--774},
doi = {10.1016/j.cld.2026.04.004}
}
EUVIMED